BIO-TECHNE Corp Business Combination, Contingent Consideration, Liability, Noncurrent
BIO-TECHNE Corp (TECH) had Business Combination, Contingent Consideration, Liability, Noncurrent of $7.00 million as of 2022-12-31, per its 10-Q filed 2023-02-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2023-08-23
- 2022-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $7.00M.
- 2022-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $8.10M.
- 2022-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $5.00M.
- 2022-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $4.80M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2022-12-31 | $7.00M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $8.10M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $5.00M 10-K · filed 2023-08-23 |
| 2022-03-31 | $4.80M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $7.00M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $17.60M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $25.40M 10-K · filed 2022-08-24 |
| 2021-03-31 | $7.10M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $5.60M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $199.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $199.00K 10-K · filed 2021-08-25 |
| 2020-03-31 | $1.70M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.68M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $5.13M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $9.20M 10-K · filed 2020-08-26 |
| 2019-03-31 | $2.20M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $6.00M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $6.80M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $3.30M 10-K · filed 2018-08-27 |
| 2017-03-31 | $3.20M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $28.60M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $32.40M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $38.50M 10-K · filed 2017-09-07 |
| 2015-06-30 | $39.02M 10-K · filed 2016-08-29 |
| 2015-03-31 | $35.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $35.00K 10-Q · filed 2015-02-09 |
| 2014-06-30 | $0.00 10-K · filed 2015-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |